Latest news with #180LifeSciences
Yahoo
7 days ago
- Business
- Yahoo
ETHZilla Follows Strategy's Playbook With Ethereum Treasury Plans. Its Stock Is Soaring
Shares of the former 180 Life Sciences (ATNF) soared Wednesday after the biotechnology company said it plans to rebrand as ETHZilla and will pursue an Ether treasury strategy. The stock jumped as much as 70% Wednesday morning, before paring back. The shares were up about 5% in recent trading, leaving the stock's year-to-date gains around 500%. The company, which was originally formed to focus on developing therapeutics in chronic pain, inflammation and fibrosis, said it now holds almost $350 million in Ether, the second-biggest cryptocurrency after Bitcoin, and plans to buy more. The price of the Ether hovered near all-time highs Wednesday at over $4,700 and has added close to half its value in 2025 amid optimism about a more crypto-friendly regulatory environment under the Trump administration. The move by ETHZilla, which counts billionaire Peter Thiel among its backers, echoes the playbook of Strategy (MSTR), formerly known as MicroStrategy, which has become the largest corporate holder of Bitcoin as part of its Bitcoin treasury strategy. The price of Bitcoin, which hovered near all-time highs Wednesday at about $121,600, has added close to a third of its value in 2025. Shares of Strategy have also climbed by roughly a third over the same period. Read the original article on Investopedia
Yahoo
7 days ago
- Business
- Yahoo
AMD, KinderCare, 180 Life Sciences: Trending Tickers
AMD (AMD) stock is jumping to its highest level since July, days after the company made a deal with the White House on Chinese chip sales KinderCare (KLC) stock is plunging after the company reported disappointing second quarter results, which led to two analyst downgrades. 180 Life Sciences (ATNF) stock is skyrocketing after the company announced it holds over 82,000 ethereum (ETH-USD) tokens. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. Now time for some of today's trending tickers. We are watching AMD, Kinder and 180 Life Sciences. First up, AMD shares popping today, shares jumping to their highest level since July. It comes just days after inking a deal with the White House to pay the US 15% of its China AI sales. Still with us, Yahoo Finances' Allie Canal. Um, it's been interesting to watch AMD's trajectory. I mean, I mean this year, we've seen outperformance. Outperformance and the gains that we're seeing today largely a continuation of that US China extension, the 90-day pause being extended once again, along with the news that Nvidia and AMD can now sell chips to China. However, they're going to have to share some of that revenue with the US government. Uh, but even as this deal draws some criticism, China remains a very important market for AMD. 24% of AMD's sales last year came from China, that's up 15% from the prior year period. CEO Lisa Su saying that the ramp up of these chips is going to help the company gain market share and that will continue to drive outperformance in the back half of the year. And separately, City was out with a new note saying that it sees 6.2 billion in AI GPU sales for 2025. That's up 23% year over year. And then in 2026, it expects sales to surge nearly 60% to 9.9 billion with Amazon, Oracle, Meta and OpenAI as some of those key customers. So the AI story just alive and well. Now City does have a neutral rating on the stock saying the China deal impact is immaterial to the results. They also have a 180 price target on shares. But overall, we see that Wall Street across the board has a moderate buy here with about 5% upside looking ahead. And Allie, next up, we got Childhood Education company Kindercare. Those shares are plunging today. It reported disappointing results for its second quarter prompting two analysts to downgrade the stock. The stock is down 19%. This company just went public last October at 24 bucks a share. And you can see it's trading under eight, Allie. Right, down 20% today. We were down as much as 30% at one point. That was the steepest intraday drop on record at all-time low. And this follows those disappointing earnings that you just mentioned. They also lowered their guidance, and a lot of this has to do with softer than expected enrollment. So, like you said, two analysts downgrades, JP Morgan cutting the stock to neutral, warning that enrollment challenges, that's likely to persist throughout the year given macro headwinds and also flat federal funding for child care block grants through 2026, which I thought was interesting. And then Barclays had a similar viewpoint. They moved to equal weight, calling the second quarter miss the final straw. They also slashed its price target to nine bucks from the prior 20, so a significant target decrease there. Now the CEO said that the results reflected continued revenue growth, uh, business resilience, but did acknowledge that enrollment trends weakened late in the quarter. So something to just keep an eye on Wall Street seems mixed right now. We've got about, uh, five buy ratings, three holds on the stock, but confidence here is clearly shaken since that IPO debut. Um and finally, we got 180 Life Sciences extending its rally after announcing its Ethereum holdings. It was a biotechnology company. Now it's an Ethereum treasury. It was up 207% on Tuesday after saying it holds 82,000 ETH tokens. The company is also backed by investor Peter Thiel. I guess we're at the point of this cycle where this is this is what we're seeing here. I remember when everybody was throwing uh blockchain in the name or metaverse this and metaverse that. And now Ethereum treasury is the latest flavor. A latest flavor, latest buzzword and this comes as ether trades at record highs and that's leading to this rally for the company. The company said it holds more than 82,000 ether tokens and at current prices there, that's worth nearly 400 million. And like you've been saying, it's the flavor of the week, the month, the year, however you want to frame it. But it comes as corporate crypto holdings. They're really making headlines more broadly and just this week, ether funds saw record inflows of $1 billion dollars as more companies add tokens to their balance sheets. So the crypto play at large, it's alive and well. You're hearing that in Washington, you're seeing that on the retail trading side. And any company that has exposure in any sense, they're doing well and they're rallying. Yeah. Um this one, by the way, does business under the name ETH Zilla, of course. So maybe at some point, they'll change that corporate name, 180 Life Sciences. We'll see. Thanks, Allie. You can scan the QR code below to track the best and worst performing stocks with Yahoo Finances Trending Tickers page. Related Videos Instacart falls on Amazon grocery, Oracle job cuts, Bullish IPO CoreWeave earnings don't answer the big question bears are asking Starbucks turnaround check-in: 1 yr. since CEO shake-up Tencent pops, Chinese tech stocks, UnitedHealth approves dividend Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
13-08-2025
- Business
- Business Insider
180 Life Sciences Stock (ATNF) Rockets 80% on $350M Ethereum Purchase
180 Life Sciences (ATNF) stock soared on Tuesday after the former biotechnology company announced its acquisition of $349 million in Ethereum (ETH). It now holds 82,186 Ether, which were bought at an average price of $3,806.71 per token. The company also noted that it still has roughly $238 million in cash equivalents. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. 180 Life Sciences' latest Ethereum purchase was part of its effort to become a crypto holding company. That's resulted in it using funds from private investments to build an ETH treasury. 180 Life Sciences has also revealed that it plans to rebrand to reflect this change, ditching its current name in favor of ETHZilla. The company will pursue a differentiated yield generation program designed to outperform traditional ETH staking via a partnership with crypto-focused venture capital firm Electric Capital. McAndrew Rudisill, Executive Chairman of 180 Life Sciences, said 'we believe that this reserve of ETH will unlock cash flow for our shareholders as we seek to deliver on our on-chain yield generation program through our external asset manager Electric Capital.' 180 Life Sciences Stock Movement Today 180 Life Sciences stock was up 78.74% on Tuesday, following an 11.33% rally yesterday. The shares have also increased 83.52% year-to-date and 91.95% over the past 12 months. Today's news brought heavy trading to ATNF stock, as some 33 million shares changed hands, compared to a three-month daily average of about 4.78 million units.
Yahoo
12-08-2025
- Business
- Yahoo
Crypto stock jumps 182% after Peter Thiel buys stake
Crypto stock jumps 182% after Peter Thiel buys stake originally appeared on TheStreet. Peter Thiel, PayPal co-founder and billionaire tech investor, has acquired 7.5% ownership of Ethereum-focused digital asset treasury (DAT) firm 180 Life Sciences Corp. Following the announcement, shares in the company jumped over 90% in early trading on Tuesday. At press time, 180 Life Sciences Corp (ATNF) is trading at $9.490, up 182%. Thiel's investment was done through a 2005 American venture capital fund called Founders Fund Growth Management, according to a filing with the U.S. Securities and Exchange Commission(SEC).ETHZilla transitioned from a biotech focus to a DAT business model, disclosing it possesses 82,186 ether bought at an average price of $3,806.71 — approximately $349 million worth — with $238 million in cash equivalents. Unlike Strategy, the first operation to transform public companies into accumulation vehicles for crypto, ETHZilla has taken one major feature right out of the playbook: leverage. Incoming chairman McAndrew Rudisill told DL News at the beginning of 2022 that he would not over-leverage his firm's Ethereum purchases. Michael Saylor of Strategy has raised billions via convertible debt in order to accumulate more Bitcoin. Convertible debt investibles pay interest similar to a bond, with the option for holders to convert their investibles into shares of the company. While it can allow companies to amass a lot of assets, it carries risk. For instance, many analysts have spoken publicly about Strategy's convertible debt that matures over 3 years, and if it cannot refinance its debt, it may have to sell Bitcoin to repay its debts, which could negatively affect market prices. Separately, BitMine, in which Thiel is a 9.1% shareholder, increased its at-the-market equity program from $4.5 billion to $24.5 billion to help finance additional Ethereum acquisitions for its benefit. At press time, Bitmine (BNMR) is trading at $65.12, nearly 10% up in the last 24 hours. Crypto stock jumps 182% after Peter Thiel buys stake first appeared on TheStreet on Aug 12, 2025 This story was originally reported by TheStreet on Aug 12, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-08-2025
- Business
- Yahoo
Why ETHZilla is skipping Michael Saylor's favourite crypto treasury ploy: Leverage
Another day, another crypto treasury company hits the wire. The newly formed ETHZilla, formerly known as the Nasdaq-listed biotech firm 180 Life Sciences, closed its $425 million investment across 60 different investors and its subsequent pivot to an Ethereum treasury company on Monday. It's an unusual beast. Compared to many of its counterparts, including the grandfather of turning public companies into crypto buying machines, Strategy, ETHZilla is leaving out one key element: leverage. McAndrew Rudisill, ETHZilla's incoming chair, isn't taking that chance on his Ethereum bet. 'There will be a point in the cycle where maybe Ether runs to $15,000 and pulls back to $10,000. That's still a 33% drawdown,' Rudisill told DL News. 'We don't want to be levered for that.' Foregoing debt Strategy's chair, Michael Saylor, has raised billions selling convertible debt, the proceeds of which are then ploughed into buying more Bitcoin. Convertible debt offers holders interest like a bond, but with the option to convert it into shares in a company. It's not risk-free, however. If Strategy can't refinance that debt at its maturity in the next three years because it doesn't have enough cash or stock, it could face a liquidity crunch and be forced to sell from its Bitcoin stockpile. And bring market prices crashing. 'Peak treasury company' With hundreds of companies turning to crypto to boost their balance sheet this year, questions swirl around how long the trend can last. The vast majority of those holdings are in Bitcoin. There are approximately 220 companies that now hold some $424 billion, 17% of all the Bitcoin on the market, according to data from Bitcoin Treasuries. Of late, Ethereum, the industry's second-largest digital asset by market cap, has become a popular choice. Ethereum co-founder Joe Lubin kicked off the trend in June after his blockchain company Consensys co-invested $425 million in the online gambling company SharpLink Gaming. Wall Street strategist and crypto bull Tom Lee joined shortly after converting a little-known Bitcoin mining firm called BitMine Immersion into one of the largest Ethereum treasury companies on the market. Campaigns to convert debt and equity into crypto are also trickling down to much smaller digital assets, such as the Ripple-founded XRP, crypto exchange Binance's native BNB, and Telegram's Toncoin. 'The new companies in those ecosystems will have a harder time getting oxygen.' And investors continue to lap it up. When the Canadian vaping company, CEA Industries, announced it would invest $500 million into BNB on July 28, the company's stock soared a whopping 548%. The stock has fallen 70% since then, raising more questions about when investors will have seen enough. 'We've probably gone through peak treasury company issuance,' Mike Novogratz, the chief executive officer of Galaxy Digital, told shareholders during his company's earnings call on Tuesday. 'The new companies in those ecosystems will have a harder time getting oxygen.' Going onchain Still, ETHZilla's Rudisill is confident his strategy will have plenty of breathing room. Unlike Bitcoin, Ethereum can generate additional yield via staking, a process where Ether is deposited into the network to validate transactions and earn rewards. 'There's going to be rapid consolidation.' On top of that, ETHZilla has tapped investment firm Electric Capital, which also invested in ETHZilla, to use the company's Ether holdings to generate more yield via different onchain lending opportunities. Rudisill declined to say how exactly. He estimates that the strategy will generate 'high single-digit to low double-digit' yield on the company's Ether. Should the crypto treasury trend grind to a halt, Rudisill suggests that the firm's lack of debt, diversified yield strategy, and strong team will separate ETHZilla from the pack. It could even open up new opportunities. Fire sale A sharp drop in crypto prices might force distressed companies to issue even more stock to raise cash or sell off their crypto holdings. Such an event would be a boon for firms with the deepest pockets. 'The big Ethereum treasury companies are going to get more Ethereum, and there's going to be rapid consolidation,' Rudisill said. 'And that's going to be positive for Ether prices.' Liam Kelly is a Berlin-based reporter for DL News. Got a tip? Email him at liam@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
